TrademarkDir
CYGNAL THERAPEUTICS
LIVE

Serial Number

87469833

Owner

VL41, Inc.

Attorney

Christina M. Licursi

First Use Date

Mar 8, 2021

Filing Date

May 31, 2017

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

CYGNAL THERAPEUTICS Trademark

Serial Number: 87469833 • Registration: 6335320

CYGNAL THERAPEUTICS is a trademark filed by VL41, Inc. on May 31, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

VL41, Inc.

55 Cambridge Parkway, 8th Floor
Cambridge, MA 02142

Entity Type: 03

Cygnal Therapeutics, Inc. (9 trademarks)

325 Vassar Street, Suite 2B
Cambridge, MA 02139

Entity Type: 03

Trademark Details

Filing Date

May 31, 2017

Registration Date

April 27, 2021

First Use Anywhere

March 8, 2021

First Use in Commerce

March 8, 2021

Published for Opposition

January 23, 2018

Goods & Services

Pharmaceutical preparations for the treatment of cancer and immune system related diseases

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Apr 27, 2026 REM1
REGISTERED-PRINCIPAL REGISTER
Apr 27, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 20, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 19, 2021 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Mar 18, 2021 SUPC
USE AMENDMENT FILED
Mar 17, 2021 IUAF
TEAS STATEMENT OF USE RECEIVED
Mar 17, 2021 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 26, 2020 EXRA
SOU EXTENSION 5 GRANTED
Sep 25, 2020 EX5G
SOU EXTENSION 5 FILED
Sep 21, 2020 EXT5
SOU TEAS EXTENSION RECEIVED
Sep 21, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 20, 2020 EXRA
SOU EXTENSION 4 GRANTED
Mar 18, 2020 EX4G
SOU EXTENSION 4 FILED
Mar 18, 2020 EXT4
SOU TEAS EXTENSION RECEIVED
Mar 18, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 19, 2019 EXRA
SOU EXTENSION 3 GRANTED
Sep 17, 2019 EX3G
SOU EXTENSION 3 FILED
Sep 17, 2019 EXT3
SOU TEAS EXTENSION RECEIVED
Sep 17, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 29, 2019 EXRA
SOU EXTENSION 2 GRANTED
Mar 28, 2019 EX2G
SOU EXTENSION 2 FILED
Mar 20, 2019 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 20, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 2, 2018 EXRA
SOU EXTENSION 1 GRANTED
Oct 1, 2018 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 26, 2018 AITU
SOU EXTENSION 1 FILED
Sep 18, 2018 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 18, 2018 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 20, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 23, 2018 NPUB
PUBLISHED FOR OPPOSITION
Jan 23, 2018 PUBO
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jan 10, 2018 ASCK
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 3, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 18, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 15, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 15, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 15, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 15, 2017 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Nov 15, 2017 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Oct 24, 2017 PBCR
ASSIGNED TO LIE
Oct 9, 2017 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 26, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 5, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 5, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 5, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 5, 2017 CNEA
ASSIGNED TO EXAMINER
Aug 30, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 7, 2017 NWOS

Related Trademarks

More from this Owner

PIONEERING EXONEURAL BIOLOGY

PIONEERING EXONEURAL BIOLOGY

PIONEERING EXONEURAL MEDICINES

PIONEERING EXONEURAL MEDICINES

PIONEERING EXONEURAL BIOLOGY

PIONEERING EXONEURAL BIOLOGY

PIONEERING EXONEURAL MEDICINES

PIONEERING EXONEURAL MEDICINES

EXONEUROGENESIS

EXONEUROGENESIS

EXONEUROGENESIS

EXONEUROGENESIS